By Year 
Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis
Pender, M. P.; Csurhes, P. A.; Smith, C.; Douglas, N. L.; Neller, M. A.; Beagley, L.; Rehan, S.; Hopkins, T. J.; Thompson, K. M.; Blum, S.; Green, K. A.; Ioannides, Z. A.; Coulthard, A.; Hooper, K. D.; Burrows, S. R.; Khanna, R.
MULTIPLE SCLEROSIS JOURNAL - 1/10/2017
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition
Forcade, Edouard; Paz, Katelyn; Flynn, Ryan; Griesenauer, Brad; Amet, Tohti; Li, Wei; Liu, Liangyi; Bakoyannis, Giorgos; Jiang, Di; Chu, Hong Wei; Lobera, Mercedes; Yang, Jianfei; Wilkes, David S.; Du, Jing; Gartlan, Kate; Hill, Geoffrey R.; MacDonald, Kelli P. A.; Espada, Eduardo L.; Blanco, Patrick; Serody, Jonathan S.; Koreth, John; Cutler, Corey S.; Antin, Joseph H.; Soiffer, Robert J.; Ritz, Jerome; Paczesny, Sophie; Blazar, Bruce R.
JCI INSIGHT - 1/06/2017
NIH - R01 CA168814
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-beta production
Du, Jing; Paz, Katelyn; Flynn, Ryan; Vulic, Ante; Robinson, Tara M.; Lineburg, Katie E.; Alexander, Kylie A.; Meng, Jingjing; Roy, Sabita; Panoskaltsis-Mortari, Angela; Loschi, Michael; Hill, Geoffrey R.; Serody, Jonathan S.; Maillard, Ivan; Miklos, David; Koreth, John; Cutler, Corey S.; Antin, Joseph H.; Ritz, Jerome; MacDonald, Kelli P.; Schacker, Timothy W.; Luznik, Leo; Blazar, Bruce R.
BLOOD - 1/05/2017
National Institutes of Health, National Cancer Institute - P01 CA142106-06A1
Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities
Dasari, Vijayendra; Bhatt, Kunal H.; Smith, Corey; Khanna, Rajiv
EXPERT REVIEW OF VACCINES - 1/04/2017